These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22731934)

  • 21. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
    Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
    Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral generic tacrolimus initiation and substitution in the Medicaid population: a new user cohort study.
    Chen L; Li C; Huo N; Mishuk AU; Hansen RA; Harris I; Kiptanui Z; Qian J
    Curr Med Res Opin; 2020 Sep; 36(9):1533-1540. PubMed ID: 32644886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
    Contin M; Alberghini L; Candela C; Benini G; Riva R
    Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient factors associated with oral generic olanzapine initiation and substitution among Medicaid beneficiaries: a new user cohort study.
    Mishuk AU; Chen L; Li C; Huo N; Hansen RA; Harris I; Kiptanui Z; Qian J
    Curr Med Res Opin; 2021 Apr; 37(4):655-664. PubMed ID: 33507825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
    Zachry WM; Doan QD; Clewell JD; Smith BJ
    Epilepsia; 2009 Mar; 50(3):493-500. PubMed ID: 18616554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brand name to generic substitution of levetiracetam in patients with epilepsy.
    Gha-Hyun L; Dae SJ
    Seizure; 2018 Aug; 60():127-131. PubMed ID: 29960217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
    Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX;
    Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
    Boylan LS
    Neurology; 2009 May; 72(21):1876; author reply 1876-7. PubMed ID: 19470974
    [No Abstract]   [Full Text] [Related]  

  • 30. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
    Markoula S; Chatzistefanidis D; Gatzonis S; Siatouni A; Siarava E; Verentzioti A; Kyritsis AP; Patsalos PN
    Seizure; 2017 May; 48():1-6. PubMed ID: 28363098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic burden associated with the use of generic antiepileptic drugs in the United States.
    Helmers SL; Paradis PE; Manjunath R; Duh MS; Lafeuille MH; Latrémouille-Viau D; Lefebvre P; Labiner DM
    Epilepsy Behav; 2010 Aug; 18(4):437-44. PubMed ID: 20580619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of antiepileptic drug substitutions on epileptic events requiring acute care.
    Rascati KL; Richards KM; Johnsrud MT; Mann TA
    Pharmacotherapy; 2009 Jul; 29(7):769-74. PubMed ID: 19558250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refilling and switching of antiepileptic drugs and seizure-related events.
    Gagne JJ; Avorn J; Shrank WH; Schneeweiss S
    Clin Pharmacol Ther; 2010 Sep; 88(3):347-53. PubMed ID: 20631693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of generic anti-epilepsy drugs in France: survey of neurologists and review of the literature].
    Biraben A; De Toffol B; Semah F; Rouaud T
    Rev Neurol (Paris); 2007 Apr; 163(4):455-61. PubMed ID: 17452947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review.
    Talati R; Scholle JM; Phung OP; Baker EL; Baker WL; Ashaye A; Kluger J; Coleman CI; White CM
    Pharmacotherapy; 2012 Apr; 32(4):314-22. PubMed ID: 22461121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription trends and psychiatric symptoms following first receipt of one of seven common antiepileptic drugs in general practice.
    Josephson CB; Engbers JDT; Jette N; Patten SB; Sajobi TT; Marshall D; Lowerison M; Wiebe S
    Epilepsy Behav; 2018 Jul; 84():49-55. PubMed ID: 29753294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generic substitution of antiepileptic drugs.
    Sander JW; Ryvlin P; Stefan H; Booth DR; Bauer J
    Expert Rev Neurother; 2010 Dec; 10(12):1887-98. PubMed ID: 21091318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.
    Rathe JØ
    Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generic substitution in the treatment of epilepsy: patient and physician perceptions.
    Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ
    Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiepileptic drug utilization in children from 1997-2005--a study from the Netherlands.
    van de Vrie-Hoekstra NW; de Vries TW; van den Berg PB; Brouwer OF; de Jong-van den Berg LT
    Eur J Clin Pharmacol; 2008 Oct; 64(10):1013-20. PubMed ID: 18618103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.